Направления и особенности формирования экспортного потенциала российских фармацевтических компаний (1142512), страница 38
Текст из файла (страница 38)
– № 28 (1). – P. 1-21.124. Bansak, C. Technology, capital spending, and capital utilization / C. Bansak,N. Morin, M. Starr // Economic Inquiry. – 2007. – № 45(3). – P. 631–645.125. Becchetti, L. Role of industrial district externalities in export and value-addedperformance: Evidence from the population of Italian firms / L. Becchetti,A. De Panizza, F. Oropallo // Regional Studies. – 2007. – № 41. – P. 601–621.126. Bernard, A. Firms in international trade / A. Bernard, J. Bradford, S.J. Redding,P.K. Schott // Journal of Economic Perspective. – 2007. – № 21.
– P. 105–130.127. BiopharmaceuticalResearchIndustryProfile[Электронныйресурс]//Pharmaceutical Research and Manufacturers of America (PhRMA). – 2016. – Режимдоступа:http://phrma.org/sites/default/files/pdf/biopharmaceutical-industry-profile.pdf (дата обращения: 14.09.2016)128.
BiopharmaceuticalResearchIndustryProfile[Электронныйресурс]//Pharmaceutical Research and Manufacturers of America (PhRMA). – 2015. – Режимдоступа: http://www.phrma.org/sites/default/files/pdf/2015_phrma_profile.pdf (датаобращения: 14.09.2016)129. Boermans, M.A. Small firm internationalization, innovation, and growth /M.A. Boermans, H. Roelfsema // International Economics and Economic Policy.– 2016.
– Volume 13. – № 2. – P. 283-296.130. Bryan, J. Training and performance in small firms / J. Bryan // International SmallBusiness Journal. – 2006. – № 24(6). – P. 635–660.131. Canada’s Pharmaceutical Industry and Prospects Industry Sector [Электронныйресурс] // Manufacturing & Life Sciences Branch – Industry Canada.
– February2014.–Режимдоступа:https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/vwapj/185PharmaProfileFeb2014_Eng.pdf/$file/PharmaProfileFeb2014_Eng.pdf(датаобращения: 14.09.2016).132. Caniёls, M.C.J. Agglomeration advantages and capability building in industrialclusters: The missing link / M.C.J.
Caniёls, H.A. Romijn // Journal of DevelopmentStudies. – 2003. – Volume 39. – № 3. – P. 129–154.133. Capo, F. Innovative Business Models in the Pharmaceutical Industry: A Case onExploiting Value Networks to Stay Competitive / F. Capo, F. Brunetta, P. Boccardelli// International Journal of Engineering Business Management. – 2014. – Volume 6.– Special Issue: Innovations in Pharmaceutical Industry. – P. 6-23.134. Chevalier, A. Does education raise productivity, or just reflect it? / A. Chevalier,C.
Harmon, I. Walker, Y. Zhu // The Economic Journal. – 2004. – № 114.– P. 499–517.135. Conconi, P. The internationalization process of firms: From exports to FDI /P. Conconi, A. Sapir, M. Zanardi // Journal of International Economics. – 2016.– Volume 99. – Issue C. – P. 16-30.136. Contractor, F.J. A Three-Stage Theory of International Expansion: The Link BetweenMulti-Nationality and Performance in the Service Sector / F.J.
Contractor, S.K.Kundu, C. Hsu // Journal of International Business Studies. – 2003. – № 34 (1).– P. 5-18.137. Cooke, P. Regionally asymmetric knowledge capabilities and open innovation:Exploring «Globalisation 2» – A new model of industry organisation / P. Cooke //Research Policy. – 2005. – № 34(8). – P. 1128-1149.138. De Clercq, D.
The internationalization of small and medium-sized firms /D. De Clercq, H.J. Sapienza, H. Crijns // Small Business Economics. – 2005.– № 24(4). – P. 409-419.139. Delgado, M. Clusters and entrepreneurship / M. Delgado, M.E. Porter, S. Stern //Journal of Economic Geography. – May 2010. – № 10(4). – P.
495-518.140. DeMartino, R. Balancing localization and globalization: Exploring the impact of firminternationalization on a regional cluster / R. DeMartino, D. McHardy,S.C. Zygliodopoulos // Entrepreneurship and Regional Development. – 2006.
– № 18.– P. 1–24.141. Development Trends and Practical Aspects of the Russian Pharmaceutical Industry(Survey results) [Электронный ресурс] // Deloitte. – 2015. – Режим доступа:186http://www2.deloitte.com/content/dam/Deloitte/ru/Documents/life-sciences-healthcare/russian-pharmaceutical-industry-2015.pdf (дата обращения: 21.09.2016).142.
Development Trends and Practical Aspects of the Russian Pharmaceutical Industry[Электронныйресурс]//Deloitte.–2014.–Режимдоступа:http://www2.deloitte.com/content/dam/Deloitte/ru/Documents/life-sciences-healthcare/russia-pharmaceutical-industry-2014.pdf (дата обращения: 21.09.2016).143. Disdier, A.-C. The puzzling persistence of the distance effect on bilateral trade /A.-C. Disdier, K. Head // The Review of Economics and Statistics. – 2008.– Volume 90. – Issue 1.
– P. 37-48.144. Donga, J. Supporting the production of pharmaceuticals in Africa / J. Donga,Z. Mirzaa // Bulletin of the World Health Organization. – 2016. – № 94. – P. 71-72.145. Dubé, F.N. The Role of Cluster Governance in the Process of FirmInternationalization: Based on the Example of Two Malaysian Halal Industrial Parks /F.N. Dubé, Y. Haijuan, H. Lijun // Asia-Pacific Social Science Review. – 2015.– № 15(1).
– P. 102-115.146. Dunning, J.H. The eclectic paradigm of international production: a restatement andsome possible extension / J.H. Dunning // Journal of International Business Studies.– 1988. – № 19(1). – P. 1–31.147. Enhancing India's Global Role in Supply of Generic Medicines. Focus onStrengthening Domestic Landscape of APIs, Regulation of Drug Trials and FosteringInnovation [Электронный ресурс] // India Pharma Summit 2013-14. Federation ofIndian Chambers of Commerce & Industry.– 2014.
– Режим доступа:http://ficci.in/spdocument/20378/position-paper-ips-2013-14.pdf (дата обращения:21.09.2016).148. Fernhaber, S.A. Exploring the Role of Industry Structure in New VentureInternationalization / S.A. Fernhaber, P.P. McDougall, B.M. Oviatt // EntrepreneurshipTheory and Practice. – 2007. – № 31(4). – P.
517-542.149. FromvisiontodecisionPharma2020[Электронныйресурс]//PricewaterhouseCoopers. – 2016. – Режим доступа: https://www.pwc.com/gx/en/pharma-life-sciences/pharma2020/assets/pwc-pharma-success-strategies.pdf (датаобращения: 15.09.2016).150. Gashi, P. Export behavior of SMEs in transition countries / P. Gashi, I. Hashi, G. Pugh// Small Business Economics. – 2014. – № 42. – P. 407–435.187151.
Generic Pharmaceutical Industry Yearbook. GPhA Conference Edition [Электронныйресурс]//Torreya–Partners.February2016.–Режимдоступа:http://www.torreyapartners.com/documents/generic-pharmaceutical-industryyearbook-torreya-feb2016-gpha.pdf (дата обращения: 15.09.2016).152. Giovannetti, G. Location, internationalization and performance of firms in Italy: amultilevel approach / G. Giovannetti, G. Ricchiuti, M. Velucchi // Applied Economics.– 2013. – № 45(18). – P. 2665-2673.153.
Global life sciences outlook 2016: Moving forward with cautious optimismресурс][Электронный//–Deloitte.–2016.Режимдоступа:https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-SciencesHealth-Care/gx-lshc-2016-life-sciences-outlook.pdf (дата обращения: 15.09.2016).154. Global life sciences outlook: Adapting in an era of transformation [Электронныйресурс] // Deloitte. – 2015. – Режим доступа: https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2015-lifesciences-report.pdf (дата обращения: 28.09.2016).155. Global Outlook for Medicines Through 2018 [Электронный ресурс] // IMS InstituteforHealthcareInformatics.––2014.Режимhttp://static.correofarmaceutico.com/docs/2014/12/01/informe_ims.pdfдоступа:(датаобращения: 28.09.2016).156. Global Pharma & Biotech M&A Report 2016 [Электронный ресурс] // IMAP.
–2016.–Режимдоступа:http://www.imap.com/Reports/Global%20Pharma%20Biotech%20MA%20Report%202016.pdf (дата обращения: 18.09.2016).157. Global pharma looks to India: Prospects for growth [Электронный ресурс] //PricewaterhouseCoopers.–2016.–Режимдоступа:http://www.pwc.com/gx/en/pharma-life-sciences/pdf/global-pharma-looks-to-indiafinal.pdf (дата обращения: 18.09.2016).158. Grøgaard, B.
An Empirical Investigation of the Role of Industry Factors in theInternationalization Patterns of Firms / B. Grøgaard, C. Gioia, G.R.G. Benito //International Studies of Management & Organization. – 2013. – № 43(1). – P. 81-100.159. Hervas-Oliver, J. Do cluster capabilities matter? An empirical application of theresource-based view in clusters / J. Hervas-Oliver, J. Albors-Garrigos //Entrepreneurship and Regional Development. – 2007. – № 19. – P.
113-136.160. Herve, H. Pharmaceutical Cluster in Andhra Pradesh [Электронный ресурс] /H. Herve, L. Bhuti, S. Agarwal, S. Kushwaha, A. Causer // Harvard Business School.188– 2013. – Режим доступа: http://www.isc.hbs.edu/resources/courses/moc-course-atharvard/documents/pdf/student-projects/india_pharmaceuticals_2013.pdf(датаобращения: 06.12.2016)161. Hеkanson, L. Epistemic Communities and Cluster Dynamics: On the Role ofKnowledge in Industrial Districts / L.
Hеkanson // Industry and Innovation. – 2005.– № 12(4). – P. 433–463.162. Indian Pharmaceuticals Industry Analysis [Электронный ресурс] // India BrandEquity Foundation. – 2015. – Режим доступа: http://www.ibef.org/download/Pharmaceuticals-March-2015.pdf (дата обращения: 18.09.2016).163. Industrial Development Report 2016. The Role of Technology and Innovation inInclusive and Sustainable Industrial Development [Электронный ресурс] // UNIDO.– 2016. – Режим доступа:https://www.unido.org/fileadmin/user_media_upgrade/Resources/Publications/EBOOK_IDR2016_FULLREPORT.pdf (дата обращения:14.09.2016).164.
Insights into Pharmaceuticals and Medical Products Africa: A Continent ofOpportunity for Pharma and Patients [Электронный ресурс] // McKinsey &Company. – 2015. – Режим доступа: http://www.mckinsey.com/insights/health_systems_and_services /africa_a_continent _of_opportunity_for_pharma_and_patients(дата обращения: 14.09.2016).165.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
